Full Text View
Tabular View
No Study Results Posted
Related Studies
[S,S]-Reboxetine Dose-Range Finding Trial
This study has been completed.
Study NCT00288652   Information provided by Pfizer

First Received on February 7, 2006.   Last Updated on June 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Additional conditions recognized in this trial
Neuralgia, Postherpetic
More general conditions related to this trial
Nervous System Diseases
Neuralgia
Neurologic Manifestations
Neuromuscular Diseases
Peripheral Nervous System Diseases
Signs and Symptoms
Interventions listed in this trial
[S,S]-Reboxetine
Additional drug interventions recognized in this trial
Reboxetine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Antidepressive Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services